Micardis HCT 80-25 MG tablet UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FK952
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,452
Award facts
- Contract value 100% obligated
- $12,451.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $12.5K to supply MICARDIS HCT 80-25 mg tablets (30-count unit dose) with a firm fixed-price structure. The contract, awarded on January 15, 2026, is scheduled for completion by January 16, 2026, and represents a non-set-aside, competitively awarded transaction. This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.9M through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
The award reflects AmerisourceBergen's established role as a critical vendor within the Defense Logistics Agency's pharmaceutical supply chain, delivering medications across multiple therapeutic domains to military treatment facilities and defense healthcare systems. As a child contract under Cencora's broader IDC with the DLA, this delivery order contributes to the agency's mission of providing essential medications to military personnel and veterans. The firm fixed-price structure and rapid completion timeline are typical of individual task orders executed under the larger pharmaceutical prime vendor agreement, demonstrating the company's capability to efficiently fulfill government procurement requirements for branded pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26FK952?
SPE2DR26FK952 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FK952 worth?
The government has obligated $12,452 on SPE2DR26FK952.
Is contract SPE2DR26FK952 an order under another contract?
Yes. SPE2DR26FK952 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK952 competed?
The extent of competition for SPE2DR26FK952 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award